Avidity Biosciences (RNA) PT Raised to $62 at Barclays
Tweet
Share
E-mailGet Alerts RNA Hot Sheet
Price: $13.98 --0%
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 3
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 3
Join SI Premium – FREE
Barclays analyst Gena Wang raised the price target on Avidity Biosciences (NASDAQ: RNA) to $62.00 (from $59.00) while maintaining a Overweight rating.
You May Also Be Interested In
- SentinelOne Inc (S) PT Raised to $25 at Canaccord
- Hyperliquid Strategies, Inc. (PURR) PT Raised to $17 at Chardan
- Workday (WDAY) PT Raised to $160 at Stifel Amid Increased AI Adoption
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
